Damora Therapeutics (DMRA) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.45% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,178.57% |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | 67.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.71% |
| Dec 31, 2025 | 307.65% |
| Sep 30, 2025 | 30.38% |
| Jun 30, 2025 | 47.15% |
| Mar 31, 2025 | 61.98% |
| Dec 31, 2024 | 11.21% |
| Sep 30, 2024 | 54.80% |
| Jun 30, 2024 | -1,100.00% |
| Mar 31, 2024 | -890.20% |
| Dec 31, 2023 | -970.91% |
| Sep 30, 2023 | -1,288.89% |
| Jun 30, 2023 | 38.81% |
| Mar 31, 2023 | 23.88% |
| Dec 31, 2022 | -3.77% |
| Sep 30, 2022 | -8.00% |